首页> 外文期刊>Environmental health perspectives. >Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease.
【24h】

Associations between PM(2.5) and Heart Rate Variability Are Modified by Particle Composition and Beta-Blocker Use in Patients with Coronary Heart Disease.

机译:PM(2.5)与心率变异性之间的关联通过冠心病患者的颗粒成分和β受体阻滞剂的使用而得到修改。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: It has been hypothesized that ambient particulate air pollution is able to modify the autonomic nervous control of the heart, measured as heart rate variability (HRV). Previously we reported heterogeneous associations between particulate matter with aerodynamic diameter < 2.5 mum (PM(2.5)) and HRV across three study centers. OBJECTIVES: We evaluated whether exposure misclassification, effect modification by medication, or differences in particle composition could explain the inconsistencies. METHODS: Subjects with coronary heart disease visited clinics biweekly in Amsterdam, the Netherlands; Erfurt, Germany; and Helsinki, Finland for 6-8 months. The standard deviation (SD) of NN intervals on an electrocardiogram (ECG; SDNN) and high frequency (HF) power of HRV was measured with ambulatory ECG during paced breathing. Outdoor levels of PM(2.5) were measured at a central site. In Amsterdam and Helsinki, indoor and personal PM(2.5) were measured during the 24 hr preceding the clinic visit. PM(2.5) was apportioned between sources using principal component analyses. We analyzed associations of indoor/personal PM(2.5), elements of PM(2.5), and source-specific PM(2.5) with HRV using linear regression. RESULTS: Indoor and personal PM(2.5) were not associated with HRV. Increased outdoor PM(2.5) was associated with decreased SDNN and HF at lags of 2 and 3 days only among persons not using beta-blocker medication. Traffic-related PM(2.5) was associated with decreased SDNN, and long-range transported PM(2.5) with decreased SDNN and HF, most strongly among persons not using beta blockers. Indicators for PM(2.5) from traffic and long-range transport were also associated with decreased HRV. CONCLUSIONS: Our results suggest that differences in the composition of particles, beta-blocker use, and obesity of study subjects may explain some inconsistencies among previous studies on HRV.
机译:背景:据推测,周围的颗粒空气污染能够改变以心率变异性(HRV)衡量的心脏自主神经控制。先前,我们在三个研究中心报告了空气动力学直径<2.5微米(PM(2.5))的颗粒物与HRV之间的异质关联。目的:我们评估了暴露分类错误,药物治疗效果改变或颗粒成分差异是否可以解释不一致之处。方法:患有冠心病的受试者每两周在荷兰阿姆斯特丹进行一次门诊。德国爱尔福特;和芬兰赫尔辛基为时6-8个月。心电图上的NN间隔的标准偏差(SDG)(SDG)和HRV的高频(HF)功率是通过动态ECG在有节奏的呼吸过程中测量的。在中心地点测量室外的PM(2.5)水平。在阿姆斯特丹和赫尔辛基,在诊所就诊前24小时测量了室内和个人的PM(2.5)。使用主成分分析将PM(2.5)分配到不同来源之间。我们使用线性回归分析了室内/个人PM(2.5),PM(2.5)元素和特定于源PM(2.5)与HRV的关联。结果:室内和个人PM(2.5)与HRV无关。仅在未使用β受体阻滞剂的患者中,室外PM(2.5)的增加与SDNN和HF的降低在2天和3天的延迟中相关。与交通相关的PM(2.5)与SDNN降低相关,而远距离运输的PM(2.5)与SDNN和HF降低相关,在未使用β受体阻滞剂的人群中最为明显。交通和远程运输中的PM(2.5)指标也与HRV降低有关。结论:我们的结果表明,颗粒组成,β-受体阻滞剂使用和肥胖症受试者的差异可能解释了先前有关HRV的研究之间的某些矛盾之处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号